LLY vs. TSM: Eli Lilly vs. Taiwan Semiconductor Mfg Stock Comparison
How do Eli Lilly (LLY) and Taiwan Semiconductor Mfg (TSM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Taiwan Semiconductor Mfg (TSM) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.
Eli Lilly (LLY) trades as ordinary local shares, while Taiwan Semiconductor Mfg (TSM) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.
| Profile Item | LLY | TSM |
|---|---|---|
| Name | Eli Lilly and Company | Taiwan Semiconductor Manufacturing Company Ltd. ADR |
| Country/Region | United States | Taiwan |
| GICS Sector | Health Care | Information Technology |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Semiconductors & Semiconductor Equipment |
| GICS Industry | Pharmaceuticals | Semiconductors & Semiconductor Equipment |
| GICS Sub-Industry | Pharmaceuticals | Semiconductors |
| Market Capitalization | 1,206.07 billion USD | 1,947.21 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 1, 1972 | October 9, 1997 |
| Security Type | Common Stock | ADR |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LLY | TSM |
|---|---|---|
| Total Return (1Y) | 52.36% | 37.26% |
| Total Return (3Y, Annualized) | 34.18% | 64.12% |
| Total Return (5Y, Annualized) | 41.08% | 28.19% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Taiwan Semiconductor Mfg (TSM) has an aggressive beta of 1.45, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.40 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | LLY | TSM |
|---|---|---|
| Volatility (1Y, Annualized) | 35.34% | 41.69% |
| Beta (5Y) | 0.40 | 1.45 |
| Max Drawdown (5Y) | -34.48% | -56.47% |
| Avg. Volume (3M) | 2.52M | 11.20M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LLY | TSM |
|---|---|---|
| Sharpe Ratio (1Y) | 1.36 | 0.79 |
| Sortino Ratio (1Y) | 2.29 | 1.15 |
Profitability
ROE (TTM)
Both Eli Lilly (LLY) at 86.02% and Taiwan Semiconductor Mfg (TSM) at 41.86% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
TSM
Semiconductors & Semiconductor Equipment industry group
41.86%
- Max
- 52.82%
- TSM
- 41.86%
- Q3
- 22.26%
- Median
- 10.58%
- Q1
- 1.29%
- Min
- -16.89%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and Taiwan Semiconductor Mfg (TSM) at 51.12% also retains a top-quartile share.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
TSM
Semiconductors & Semiconductor Equipment industry group
51.12%
- Max
- 63.80%
- TSM
- 51.12%
- Q3
- 28.36%
- Median
- 11.44%
- Q1
- 0.90%
- Min
- -37.77%
Operating Margin (TTM)
Both Eli Lilly (LLY) at 53.66% and Taiwan Semiconductor Mfg (TSM) at 58.66% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
TSM
Semiconductors & Semiconductor Equipment industry group
58.66%
- TSM
- 58.66%
- Max
- 58.66%
- Q3
- 30.23%
- Median
- 15.91%
- Q1
- 7.54%
- Min
- -25.74%
Profitability Metrics
| Metric | LLY | TSM |
|---|---|---|
| ROE (TTM) | 86.02% | 41.86% |
| ROA (TTM) | 21.06% | 20.58% |
| Net Margin (TTM) | 31.90% | 51.12% |
| Operating Margin (TTM) | 53.66% | 58.66% |
| Gross Margin (TTM) | 83.63% | 65.85% |
Growth
Revenue Growth
Taiwan Semiconductor Mfg (TSM) at 31.61% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for TSM.
EPS Growth
Both Eli Lilly (LLY) at 95.99% and Taiwan Semiconductor Mfg (TSM) at 46.41% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | LLY | TSM |
|---|---|---|
| Revenue Growth (YoY) | 44.70% | 31.61% |
| Revenue Growth (3Y CAGR) | 31.69% | 18.94% |
| EPS Growth (YoY) | 95.99% | 46.41% |
| EPS Growth (3Y CAGR) | 51.71% | 19.12% |
Financial Strength
Current Ratio (MRQ)
Taiwan Semiconductor Mfg (TSM) at 2.51 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
TSM
Semiconductors & Semiconductor Equipment industry group
2.51
- Max
- 10.33
- Q3
- 5.62
- Median
- 3.33
- TSM
- 2.51
- Q1
- 2.35
- Min
- 1.03
Debt / Equity (MRQ)
Taiwan Semiconductor Mfg (TSM) at 0.12 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
TSM
Semiconductors & Semiconductor Equipment industry group
0.12
- Max
- 1.46
- Q3
- 0.65
- Median
- 0.27
- TSM
- 0.12
- Q1
- 0.04
- Min
- 0.00
Financial Strength Metrics
| Metric | LLY | TSM |
|---|---|---|
| Current Ratio (MRQ) | 1.39 | 2.51 |
| Debt / Equity (MRQ) | 1.23 | 0.12 |
| Net Debt / EBITDA | 0.96 | -0.89 |
Dividends
Dividend Yield (TTM)
Both Eli Lilly (LLY) at 0.49% and Taiwan Semiconductor Mfg (TSM) at 1.70% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TSM
Semiconductors & Semiconductor Equipment industry group
1.70%
- TSM
- 1.70%
- Max
- 1.37%
- Q3
- 0.65%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both pay out more than their industries’ typical bands, and LLY more so: Taiwan Semiconductor Mfg (TSM) at 24.46% sits above the band, while Eli Lilly (LLY) at 21.71% exceeds every peer in its group.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TSM
Semiconductors & Semiconductor Equipment industry group
24.46%
- Max
- 49.64%
- TSM
- 24.46%
- Q3
- 21.71%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LLY | TSM |
|---|---|---|
| Dividend Yield (TTM) | 0.49% | 1.70% |
| Dividend Payout Ratio (TTM) | 21.71% | 24.46% |
Valuation
P/E Ratio (TTM)
Taiwan Semiconductor Mfg (TSM) at 24.33 is near its industry’s usual P/E ratio, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — LLY needs stronger growth or earnings quality to justify the premium.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
TSM
Semiconductors & Semiconductor Equipment industry group
24.33
- Max
- 110.34
- Q3
- 66.81
- Median
- 37.02
- TSM
- 24.33
- Q1
- 23.96
- Min
- 8.12
P/S Ratio (TTM)
Taiwan Semiconductor Mfg (TSM) at 0.39 sits in the cheaper P/S ratio quartile while Eli Lilly (LLY) at 13.95 prices around its industry’s middle — TSM costs less per dollar of sales, though read it alongside growth and margins.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
TSM
Semiconductors & Semiconductor Equipment industry group
0.39
- Max
- 21.42
- Q3
- 12.27
- Median
- 5.76
- Q1
- 2.73
- TSM
- 0.39
- Min
- 0.00
P/B Ratio (MRQ)
Measured against book value, both Eli Lilly (LLY) at 29.96 and Taiwan Semiconductor Mfg (TSM) at 71.65 look expensive — each P/B ratio sits above its industry’s benchmark range.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
TSM
Semiconductors & Semiconductor Equipment industry group
71.65
- TSM
- 71.65
- Max
- 14.06
- Q3
- 7.44
- Median
- 4.29
- Q1
- 2.30
- Min
- 0.20
Valuation Metrics
| Metric | LLY | TSM |
|---|---|---|
| P/E Ratio (TTM) | 43.95 | 24.33 |
| P/S Ratio (TTM) | 13.95 | 0.39 |
| P/B Ratio (MRQ) | 29.96 | 71.65 |
| Free Cash Flow Yield (TTM) | 0.77% | 61.78% |